Venturi Wealth Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.81M | Buy |
25,930
+490
| +2% | +$34.2K | 0.09% | 131 |
|
2025
Q1 | $1.87M | Buy |
25,440
+1,044
| +4% | +$76.7K | 0.1% | 125 |
|
2024
Q4 | $1.6M | Sell |
24,396
-1,400
| -5% | -$91.7K | 0.08% | 149 |
|
2024
Q3 | $2.01M | Buy |
25,796
+2,968
| +13% | +$231K | 0.11% | 112 |
|
2024
Q2 | $1.78M | Buy |
22,828
+2,771
| +14% | +$216K | 0.11% | 117 |
|
2024
Q1 | $1.36M | Sell |
20,057
-3,301
| -14% | -$224K | 0.09% | 142 |
|
2023
Q4 | $1.57M | Sell |
23,358
-758
| -3% | -$51.1K | 0.11% | 110 |
|
2023
Q3 | $1.63M | Buy |
24,116
+53
| +0.2% | +$3.59K | 0.13% | 96 |
|
2023
Q2 | $1.72M | Sell |
24,063
-2,338
| -9% | -$167K | 0.14% | 85 |
|
2023
Q1 | $1.83M | Buy |
26,401
+2,820
| +12% | +$196K | 0.15% | 91 |
|
2022
Q4 | $1.6M | Buy |
23,581
+207
| +0.9% | +$14K | 0.14% | 102 |
|
2022
Q3 | $1.28M | Sell |
23,374
-770
| -3% | -$42.2K | 0.12% | 104 |
|
2022
Q2 | $1.59M | Buy |
24,144
+99
| +0.4% | +$6.53K | 0.14% | 89 |
|
2022
Q1 | $1.6M | Buy |
24,045
+1,161
| +5% | +$77K | 0.12% | 93 |
|
2021
Q4 | $1.33M | Buy |
22,884
+1,195
| +6% | +$69.6K | 0.1% | 129 |
|
2021
Q3 | $1.3M | Buy |
21,689
+996
| +5% | +$59.8K | 0.11% | 116 |
|
2021
Q2 | $1.24M | Buy |
20,693
+911
| +5% | +$54.6K | 0.11% | 133 |
|
2021
Q1 | $984K | Buy |
19,782
+10,071
| +104% | +$501K | 0.09% | 153 |
|
2020
Q4 | $485K | Sell |
9,711
-4,043
| -29% | -$202K | 0.05% | 221 |
|
2020
Q3 | $753K | Buy |
13,754
+97
| +0.7% | +$5.31K | 0.09% | 154 |
|
2020
Q2 | $722K | Buy |
+13,657
| New | +$722K | 0.1% | 131 |
|
2019
Q1 | – | Sell |
-8,474
| Closed | -$325K | – | 244 |
|
2018
Q4 | $325K | Buy |
+8,474
| New | +$325K | 0.05% | 193 |
|